000			02045 a2200577 4500
005			20250513061410.0
264		0	_c19930923
008			199309s 0 0 eng d
022			_a0732-183X
024	7		_a10.1200/JCO.1993.11.9.1652 _2doi
040			_aNLM _beng _cNLM
100	1		_aList, A F
245	0	0	_aPhase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia. _h[electronic resource]
260			_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cSep 1993
300			_a1652-60 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aATP Binding Cassette Transporter, Subfamily B, Member 1
650	0	4	_aAcute Disease
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacokinetics
650	0	4	_aCarrier Proteins _xgenetics
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aCyclosporine _xadverse effects
650	0	4	_aDaunorubicin _xadministration & dosage
650	0	4	_aDrug Resistance _xgenetics
650	0	4	_aFemale
650	0	4	_aGene Expression
650	0	4	_aHumans
650	0	4	_aLeukemia, Myeloid _xblood
650	0	4	_aMale
650	0	4	_aMembrane Glycoproteins _xgenetics
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Proteins _xgenetics
650	0	4	_aPhenotype
650	0	4	_aSurvival Analysis
650	0	4	_aTreatment Outcome
700	1		_aSpier, C
700	1		_aGreer, J
700	1		_aWolff, S
700	1		_aHutter, J
700	1		_aDorr, R
700	1		_aSalmon, S
700	1		_aFutscher, B
700	1		_aBaier, M
700	1		_aDalton, W
773	0		_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 11 _gno. 9 _gp. 1652-60
856	4	0	_uhttps://doi.org/10.1200/JCO.1993.11.9.1652 _zAvailable from publisher's website
999			_c8101962 _d8101962